Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Winder

Showing results (51-60 of 92) with videos related to

Pageof 10
Sort By:
Journal of Hepatocellular Carcinoma|June 21, 2021
Rates of Hepatocellular Carcinoma After Start of Treatment for Chronic Hepatitis C Remain High with Direct Acting Antivirals: Analysis from a Swiss Liver Transplant CenterFatih Karbeyaz, Seraphina Kissling, Paul Julius Jaklin, et al.
Wiener Klinische Wochenschrift|August 23, 2018
Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer : A retrospective analysisEva Asamer, Joanna Szkandera, Paul Gibiser, et al.
Journal of Cancer Research and Clinical Oncology|February 10, 2023
Cell-free circulating RAS mutation concentrations significantly impact the survival of metastatic colorectal cancer patientsAxel Muendlein, Kathrin Geiger, Christine Heinzle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2010
Germline polymorphisms in genes involved in the IGF1 pathway predict efficacy of cetuximab in wild-type KRAS mCRC patientsThomas Winder, Wu Zhang, Dongyun Yang, et al.
International Journal of Cancer|November 25, 2010
Germline polymorphisms in genes involved in the CD44 signaling pathway are associated with clinical outcome in localized gastric adenocarcinomaThomas Winder, Yan Ning, Dongyun Yang, et al.
BMC Cancer|June 17, 2017
Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance: an observational cohort studyJakob Michael Riedl, Florian Posch, Angelika Bezan, et al.
Therapeutic Advances in Medical Oncology|November 16, 2020
Practical considerations in the use of regorafenib in metastatic colorectal cancerFotios Loupakis, Lorenzo Antonuzzo, Jean-Baptiste Bachet, et al.
Journal of Orthopaedic Surgery and Research|May 1, 2026
Nationwide treatment patterns and outcomes of localised soft tissue sarcoma in Austria: real-world data from the Austrian Sarcoma RegistryMaria Anna Smolle, Sonja Hasenschwandtner, Andreas Reichinger, et al.
British Journal of Haematology|August 4, 2021
Serological SARS-CoV-2 antibody response, potential predictive markers and safety of BNT162b2 mRNA COVID-19 vaccine in haematological and oncological patientsMagdalena Benda, Beatrix Mutschlechner, Hanno Ulmer, et al.
International Journal of Cancer|July 22, 2010
Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line modelsYan Ning, Philipp C Manegold, Young Kwon Hong, et al.
Pageof 10

Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
Journal of Hepatocellular Carcinoma|June 21, 2021
Rates of Hepatocellular Carcinoma After Start of Treatment for Chronic Hepatitis C Remain High with Direct Acting Antivirals: Analysis from a Swiss Liver Transplant CenterFatih Karbeyaz, Seraphina Kissling, Paul Julius Jaklin, et al.
Wiener Klinische Wochenschrift|August 23, 2018
Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer : A retrospective analysisEva Asamer, Joanna Szkandera, Paul Gibiser, et al.
Journal of Cancer Research and Clinical Oncology|February 10, 2023
Cell-free circulating RAS mutation concentrations significantly impact the survival of metastatic colorectal cancer patientsAxel Muendlein, Kathrin Geiger, Christine Heinzle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2010
Germline polymorphisms in genes involved in the IGF1 pathway predict efficacy of cetuximab in wild-type KRAS mCRC patientsThomas Winder, Wu Zhang, Dongyun Yang, et al.
International Journal of Cancer|November 25, 2010
Germline polymorphisms in genes involved in the CD44 signaling pathway are associated with clinical outcome in localized gastric adenocarcinomaThomas Winder, Yan Ning, Dongyun Yang, et al.
BMC Cancer|June 17, 2017
Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance: an observational cohort studyJakob Michael Riedl, Florian Posch, Angelika Bezan, et al.
Therapeutic Advances in Medical Oncology|November 16, 2020
Practical considerations in the use of regorafenib in metastatic colorectal cancerFotios Loupakis, Lorenzo Antonuzzo, Jean-Baptiste Bachet, et al.
Journal of Orthopaedic Surgery and Research|May 1, 2026
Nationwide treatment patterns and outcomes of localised soft tissue sarcoma in Austria: real-world data from the Austrian Sarcoma RegistryMaria Anna Smolle, Sonja Hasenschwandtner, Andreas Reichinger, et al.
British Journal of Haematology|August 4, 2021
Serological SARS-CoV-2 antibody response, potential predictive markers and safety of BNT162b2 mRNA COVID-19 vaccine in haematological and oncological patientsMagdalena Benda, Beatrix Mutschlechner, Hanno Ulmer, et al.
International Journal of Cancer|July 22, 2010
Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line modelsYan Ning, Philipp C Manegold, Young Kwon Hong, et al.
Pageof 10